(Reuters) -Cybersecurity firm SailPoint said on Tuesday it is now seeking a valuation of up to $12.57 billion in its U.S. initial public offering, marking the year's first major test of investor ...
More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...
Goldman Sachs initiated coverage on Silence Therapeutics (NASDAQ:SLN), currently trading at $4.92 with a market cap of $232.3 million, with a Sell rating and a price target of $6.00. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback